Available in print and e-book
They’ve forgotten what makes us human.
On planet Eamine, twenty-one-year-old Alina must protect her baby when Mandin is born with a remarkable DNA anomaly. The colony’s central corporation wants Mandin for an experimental treatment program. Trained by the Expeditionary Academy, Alina knows how to survive Eamine’s harsh environment and flees to keep Mandin safe.
While Alina tries to uncover the truth, she finds herself relying on Kiean, a gruff pilot who protects her from threats in the midst of her new surroundings. As an upcoming rebellion brews, Alina must discover who she can trust, facing choices about family, life, and love. Despite the risk, Alina is determined to safeguard Mandin from the colony‘s most powerful institutions.
Editorial Reviews
☆ ☆ ☆ ☆ ☆ “Diana Fedorak’s tale has the potential to pose profound scientific and philosophical questions about medical ethics and humanity’s future.” —Vincent Dubaldo, Reader’s Favorite
☆ ☆ ☆ ☆ ☆ “Children of Alpheios is a page-turner that will fascinate those who love captivating stories set in other worlds…This is one of the best books I have ever read.” —Astrid Lustulin, Reader’s Favorite
☆ ☆ ☆ ☆ ☆ “Children of Alpheios is a magnificent story that I loved.”
—Keith Mbuya, Reader’s Favorite
Recommended Reading:
Children of Alpheios is an entertaining, thought-provoking novel for readers who appreciate immersing themselves in profound human choices in sci-fi settings. Fedorak gives us an intimate look into Alina and her world."
—Tucker Lieberman, Independent Book Review
"Readers of medical thrillers and action stories will find Children of Alpheios a futuristic sci-fi mix that can appeal to a wide audience through a story that is vividly portrayed, action-packed, and hard to put down."
—D. Donovan, Senior Reviewer, Midwest Book Review
“A cleverly plotted sci-fi thriller with a strong, likeable protagonist to root for. Highly recommended!"
—E. Taylor, The Wishing Shelf
Excerpt from Children of Alpheios:
Alina rolled the vial in between her fingertips, noting Mandin's blood sample contained a purplish undertone. They had never requested her permission for an experimental lab test. Dr. Olek would have informed her. Did Dr. Daxmen draw the sample himself when she had stepped away for a moment? She fumbled with the vial and wrapped her fist around it. "And if Mandin's body accepts the treatment, what's the outcome?"
"We should be able to preserve his very special talents while ridding him of his seizures."
Goosebumps rankled the nape of her neck at the sight of the purplish undertone. It looked vaguely familiar, but she couldn't place it. She wanted to dispose of the vial, but instead, passed it back. Ms. Silver placed the tubes in the refrigerator.
"Are you sure it's safe for infants?"
Ms. Silver brushed a piece of invisible lint off her lapel. "We believe so. Although we need some paperwork from you before you bring him in."
"What exactly?"
"We can dispense with the non-disclosure agreement we discussed earlier, provided you consent to Mandin's Phase Three treatment. The other item would be your agreement in allowing us to file a patent for Mandin's DNA." The director picked up the glass tablet and scrolled through the screen. "As a matter of fact, I have the forms right here."